Is It Time to Expand the Indication of DOAC to Patients With Cardiac Amyloidosis and Atrial Fibrillation?

Int J Heart Fail. 2024 Jan 22;6(1):44-45. doi: 10.36628/ijhf.2024.0002. eCollection 2024 Jan.

Authors

So-Ryoung Lee^{1

2}, Jung-Min Choi¹

Affiliations

¹ Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
² Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

No abstract available

Publication types

Editorial